Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...

Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in ...

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...

Medical experts discuss strategies for patient education on managing potential adverse events of lorlatinib and other ALK ...

The study's findings have implications for early detection and prevention of breast cancer, suggesting that chromosomal ...

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...

ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...

ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...

Panelists discuss how adverse event profiles, management strategies, and patient education approaches differ among EGFR-targeted therapies for non–small cell lung cancer, including oral tyrosine ...

ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...

Panelists discuss how the availability of subcutaneous amivantamab influences nursing approaches to patient care and education, with Squires sharing strategies for ensuring patients understand the new ...